Migraine Treatment Recommendations
For acute migraine treatment, NSAIDs (ibuprofen 400-600mg or naproxen 500-550mg) and triptans (sumatriptan 50mg) are first-line options, while preventive therapy should be initiated with beta-blockers (propranolol 80-240mg/day) or CGRP antagonists for patients with frequent migraines. 1
Acute Treatment Options
First-Line Treatments
NSAIDs:
Acetaminophen:
- 1000mg 1
- Avoid in patients with liver disease
- Can be combined with aspirin and caffeine for mild to moderate headaches (avoid in patients with peptic ulcer disease or bleeding disorders)
Second-Line Treatments
Triptans:
- Sumatriptan 50mg orally is the recommended starting dose 1, 2
- 50mg dose provides similar efficacy to 100mg with fewer adverse effects 2, 3
- Maximum daily dose: 200mg in a 24-hour period 2
- If first dose doesn't work, a second dose may be taken after 2 hours 2
- Limit use to no more than 9 days per month to prevent medication overuse headache 1
- Contraindicated in patients with cardiovascular disease 4
CGRP Antagonists:
Other Acute Options
- Greater occipital nerve block for short-term treatment 1
- Normobaric oxygen therapy 1
- For severe attacks or significant nausea/vomiting: Sumatriptan 6mg subcutaneously (most effective route but with higher incidence of adverse events) 1, 5
Preventive Treatment
When to Consider Prevention
- Frequent migraines (especially approaching 15 headache days per month) 6
- Significant disability despite acute treatment
- Risk of progression from episodic to chronic migraine 6
- Medication overuse or contraindication to acute treatments
First-Line Preventive Options
Beta-blockers:
Tricyclic Antidepressants:
- Amitriptyline (30-150 mg/day) 1
- Start low (10mg) and increase gradually
- Particularly effective for mixed migraine and tension-type headaches
- Use with caution in elderly patients and those with cardiac comorbidities due to anticholinergic effects
CGRP Monoclonal Antibodies:
- Erenumab, fremanezumab, galcanezumab 1
- Strong option for preventive therapy in patients with frequent migraines
- Galcanezumab specifically recommended for episodic cluster headache prevention
Anticonvulsants:
- Divalproex sodium (500-1500 mg/day) 1
- Consider for refractory cases
- Requires monitoring for weight gain, hair loss, and tremor
Non-Pharmacological Approaches
Lifestyle Modifications:
Physical Interventions:
Treatment Pearls and Pitfalls
Early Treatment: Treating early during mild pain phase provides significantly better outcomes than waiting until pain is moderate or severe 5
Medication Overuse: Strictly limit acute medications to prevent medication overuse headache:
Headache Recurrence: Headaches may recur in 21-57% of patients after sumatriptan treatment, but most respond to a second dose 4
Monitoring: Schedule follow-up in 4-6 weeks to assess treatment effectiveness 1
Preventive Medication Expectations: Allow 2-3 months for full benefit of preventive medications to develop 1
Special Populations: